Pick of the Week - Dr Reddy’s Laboratories Ltd
Dr Reddy’s Laboratories Ltd (DRREDDY) is a global pharmaceutical company committed to providing access to affordable and innovative medicines.
767 Views
Dr. Reddy’s Laboratories Ltd - New Launches to Add Growth and Profitability!
The growth was driven by the launch of gRevlimid in the US and sequential improvement in Russian sales, which was only partially offset by price...
185 Views
Dr. Reddy's Laboratories - Management Meet Update
We hosted the management of Dr. Reddy’s Laboratories Ltd at our Annual Investor Conference to discuss the business outlook. The company expects to...
324 Views
Dr. Reddy's Laboratories - Strong Growth Across Business Segments
We reiterate our Buy rating on Dr. Reddy’s Laboratories (DRL) with a target price (TP) of Rs5,424. 4QFY22 earnings performance was above expectations
358 Views
Dr Reddys Labs: Stable Results Despite Industry Headwinds; Maintain BUY
The company is building a global pipeline of biosimilars, developments of NCE for Immuno-oncology, and building up a Neutraceuticals portfolio,...
496 Views